Skip to content

Public FDA record

Z-1258-2021: ThermaCor 1200 Disposable Sets Components of the Smisson-Cartledge Biomedical ThermaCor 1200 Rapid Therm

Recall record Z-1258-2021 for Smisson-Cartledge Biomedical, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1258-2021
Company in FDA record
Smisson-Cartledge Biomedical, LLC
FDA classification date
Mar 26, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

Customers are being notified of results from a Toxicological Risk Assessment related to potential for aluminum ions to leach into warmed fluids.

Source facts

Action
The firm issued an URGENT MEDICAL DEVICE SAFETY NOTIFICATION by email and letter on 02/18/2021. The letter explained the issue and the hazard and provided the user with specific parameters for the safe usage of the device. Distributors: Further distribute the product to the hospitals and clinics where they were used. Keep accurate records and send a complete Customer List to: Smisson-Cartledge Biomedical, LLC Attn: Donna Stevenson, 487 Cherry Street Macon, GA 31201 USA Send an updated Customer List on a weekly basis. For additional information contact - Calder Clay 478-330-6203 On 03/31/2021, Smisson-Cartledge Biomedical, LLC issued an updated letter, an URGENT MEDICAL DEVICE CORRECTION NOTIFICATION, to its consignees with a laminated card to attach to the pole clamp knob with the following warning: Warning: Use of this device under certain clinical use conditions may result in exposure to aluminum at levels that raise a toxicological concern. To mitigate the risk of exposure to aluminum, users should be aware of the following: 1. Potentially higher aluminum leaching from these devices may occur when using lower flow rates (i.e., 10mL/HOUR), with certain solutions and blood products, and longer duration of use. 2. When possible, the use of balanced electrolyte solutions (e.g., Lactated Ringers solution) should be limited to less than 6 hours. 3. Limit the use of the ThermaCor 1200 Rapid Thermal Infuser and Cassettes to a maximum total fluid volume of 25 Liters or up to a maximum of 12 consecutive hours, whichever occurs first. 4. The following patient populations are especially at risk: Pediatric patients, particularly neonates and infants, Pregnant women, Elderly, Patients with poor renal function or on dialysis 5. Evaluate the benefits and risks of using the device versus the patient condition. Note: These parameters do not reflect typical clinical usage. NO RETURN OF THE PRODUCT IS NECESSARY.
Initiated
2021-02-18
Root cause
Component design/selection
Terminated
2024-04-26
Distribution
Nationwide Distribution in US and international via 2 US distributors (VA and GA)
Recall number
Z-1258-2021
Recall status
Terminated
CDRH record ID
184598
FDA classified
2021-03-26
Recall event number
86808

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗